Wiley Bros. Aintree Capital, LLC Novo Nordisk A S Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 128,345 shares of NVO stock, worth $11.3 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
128,345
Previous 47,526
170.05%
Holding current value
$11.3 Million
Previous $5.66 Million
95.12%
% of portfolio
0.14%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,881Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.76 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.36 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.14 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.11 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1.07 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $199B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...